Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02317328 · ClinicalTrials.gov registry record

Adaptive Optics Retinal Imaging

A clinical trial of Healthy Volunteers and Eye Diseases, sponsored by National Eye Institute (NEI).

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT02317328: Recruiting study of Healthy Volunteers and Eye Diseases, sponsored by National Eye Institute (NEI).

NCT02317328 is a study of Healthy Volunteers and Eye Diseases that is actively recruiting participants, run by National Eye Institute (NEI). The registered enrollment target is 1,000 participants, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02317328, a study of Healthy Volunteers and Eye Diseases, is actively recruiting participants, sponsored by National Eye Institute (NEI).

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

Background: \- By the time diseases of the retina are detected, serious damage has often already been done. Researchers want to find better ways of viewing the retina. One way called adaptive optics may help detect problems earlier. Objectives: \- To study if adaptive optics can help find better ways to diagnose, treat, and manage retinal diseases. Eligibility: * People over age 12 with an eye disease. * Healthy volunteers over age 12. Design: * Participants will be screened with medical history and eye exams. These may include dilating pupils and taking pictures of the eyes. * Participants will have 1 or more study visits. They will have: * Medical and eye history. * Questions about their medications. * Eye exam including pupil dilation. * Adaptive optics imaging. After dilation, participants sit still while looking into an adaptive optics instrument. They look at specific places and images are taken of their retina. * They may also have: * More images. * Perimetry. Participants look into a lens and press a button when they see a light. * Color vision tests. * Electroretinogram. Participants will get numbing eye drops and special contact lenses. A small metal electrode will be put on their forehead. They will look at flashing lights and try not to blink.

Primary Outcome

Qualitative and quantitative assessment of AO images with comparison of normal and diseased states.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2015-02-20
Est. Completion 2028-03-31
National Eye Institute (NEI)

221 total trials

What NCT02317328 shows while recruiting

NCT02317328 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 478-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (109% higher).

The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 0 interventions.

NCT02317328 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02317328 about?

NCT02317328 is a clinical study titled "Adaptive Optics Retinal Imaging". Background: \- By the time diseases of the retina are detected, serious damage has often already been done. Researchers want to find better ways of viewing the retina. One way called adaptive optics may help detect problems earlier. Objectives: \- To study if adaptive optics can help find better ...

What is the current status of trial NCT02317328?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2015-02-20. Estimated completion is 2028-03-31.

What conditions does trial NCT02317328 study?

This clinical trial studies the following conditions: Healthy Volunteers, Eye Diseases.

Who is sponsoring clinical trial NCT02317328?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02317328 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02317328's enrollment target sits among peer trials

1,000 14th of 283 higher than 265 of 283 other Healthy Volunteers trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02317328, the US trial registry maintained by the National Library of Medicine. NCT02317328 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.